Capecitabine and Radiotherapy in the Adjuvant Treatment of Resistant Breast Cancer
NCT03958721
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Resistant Breast Cancer
Non-metastatic Invasive Breast Cancer
Interventions
DRUG:
Capecitabine
RADIATION:
Radiotherapy
Sponsor
A Bapsi Chakravarthy, MD